TissGeneSummary for LELP1 |
Gene summary |
Basic gene information | Gene symbol | LELP1 |
Gene name | late cornified envelope-like proline-rich 1 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 1q21.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001010857.2, | |
Description | late cornified envelope-like proline-rich protein 1novel small proline rich proteinnovel small proline-rich protein | |
Modification date | 20141207 | |
dbXrefs | MIM : 611042 | |
HGNC : HGNC | ||
Ensembl : ENSG00000203784 | ||
HPRD : 17303 | ||
Vega : OTTHUMG00000013935 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_LELP1 | |
BioGPS: 149018 | ||
Pathway | NCI Pathway Interaction Database: LELP1 | |
KEGG: LELP1 | ||
REACTOME: LELP1 | ||
Pathway Commons: LELP1 | ||
Context | iHOP: LELP1 | |
ligand binding site mutation search in PubMed: LELP1 | ||
UCL Cancer Institute: LELP1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of LELP1 | ||
Description by TissGene annotations | Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for LELP1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for LELP1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for LELP1 |
TissGeneSNV for LELP1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.E45K | SKCM | 3 |
p.S85F | SKCM | 3 |
p.P21L | SKCM | 2 |
p.C61Y | LUAD | 1 |
p.R42C | PRAD | 1 |
p.P16R | LUSC | 1 |
p.P70S | SKCM | 1 |
p.P80S | SARC | 1 |
p.E24V | LUAD | 1 |
p.S2L | BRCA | 1 |
p.E50K | SKCM | 1 |
p.D5N | SKCM | 1 |
p.R42C | GBM | 1 |
p.E50G | SKCM | 1 |
p.P73L | SKCM | 1 |
p.E15* | LUAD | 1 |
p.P95S | SKCM | 1 |
p.Q72L | LUAD | 1 |
p.P33H | LUSC | 1 |
p.Q32H | SARC | 1 |
p.Q41K | COAD | 1 |
p.P21S | SKCM | 1 |
p.S63* | LUAD | 1 |
p.P66S | SKCM | 1 |
p.P62H | LUAD | 1 |
p.E50D | SKCM | 1 |
p.S2L | UCEC | 1 |
p.C43W | UCEC | 1 |
p.P33S | UCEC | 1 |
p.P79S | HNSC | 1 |
p.C94Y | BRCA | 1 |
Top |
TissGeneCNV for LELP1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for LELP1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | TopHat-Fusion | LUSC | TCGA-98-8023-01A | ZHX2-LELP1 | 5'UTR-5'UTR | chr8:123794184 | chr1:153177162 |
TCGAfusionPortal | PRADA | LUAD | TCGA-97-A4M3-01A | LMX1A-LELP1 | CDS-5UTR | Chr1:165322313 | Chr1:153177163 |
Top |
TissGeneNet for LELP1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for LELP1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for LELP1 |
TissGeneDrug for LELP1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for LELP1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |